Prevalence of Myocardial Injury in Gastrointestinal Surgery Patients
NCT ID: NCT02885415
Last Updated: 2017-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
101 participants
OBSERVATIONAL
2016-08-31
2017-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to determine the prevalence of myocardial injury in gastrointestinal surgery patients and to establish baseline data to allow evaluation of the potential benefit of RIPC (remote ischemic preconditioning) in these patients
Significance:
In available literature was one study including 51 patients that focused on postoperative arrhythmias in colorectal surgery . We think this study is important to establish more specifically the prevalence of myocardial injury in this cohort of patients so we can measure in our future research if RIPC or any other protective method could produce significant effect.
Study Design:
Prospective Observational cohort Study
Study Objectives:
To determine the prevalence of myocardial injury in patients undergoing gastrointestinal surgery
Patients and Locations:
Patients older than 18 years undergoing major resectional gastrointestinal surgery in Galway University Hospitals (UCHG, Mayo university Hospital), The Midland Regional Hospital, Tullamore and Letterkenny University Hospital will be asked to join the study and will considered eligible after informed consent and information handouts provided.
Protocol:
After informed consent patients' pre-op demographic data, co-morbidities, bloods including troponin and ECG will be recorded. Serum troponin levels will be measured daily for the first 72 hours and a 12-lead electrocardiogram will be performed at 48 hours post-surgery. There will be 1 year flow up for candidates
Data Handling:
The data for each hospital will be kept locally and patients will be allocated numbers for later data analysis. The pooled data will be analyzed using a secure computer in an NUI Galway research facility building. No patients' name or any other identifier will be associated with this data except for their study number assigned earlier
Primary Outcome:
Prevalence of myocardial injury by comparing pre and post-op troponin and ECGs. The diagnosis of myocardial injury will be determined by a cardiologist after examining troponin and ECGs results using SAVES trial criteria (5).
Perioperative Myocardial injury will include silent myocardial infarctions as determined by the study cardiologist upon examination of study ECGs and troponin results. The diagnosis of a myocardial injury will require the presence of at least two of the following:
1. Characteristic ischemic symptoms lasting at least 20 minutes
2. Electrocardiographic changes including acute ST elevation followed by the appearance of Q waves or the loss of R waves, the development of new left bundle branch block, new persistent T wave inversion lasting at least 24 hours or new ST segment depression persisting over 24 hours
3. Positive troponin above normal range (0-14)
4. New-onset arrhythmia (ventricular or supraventricular tachycardia or fibrillation) with an associated rise in troponin levels
5. Alternatively, myocardial injury will be recorded if the patient develops sudden unexpected cardiac death involving cardiac arrest with symptoms suggestive of myocardial ischemia and accompanied by presumably new ST elevation or new left bundle branch block and/or fresh thrombus on coronary angiography and/or at post-mortem, but death occurring before blood samples could be obtained or at a time before the appearance of cardiac troponin I or T in the blood.
Other Data:
* Age
* Gender
* Procedure type
* Renal Profile (Renal impairment will be consider when interpreting Troponin values)
* ECG
* Ethnicity
* Diabetes
* BP
* History of Cardiac event
* Other Comorbidities
* Smoking history
* NYHA classification (New York Heart Association )
* Medication at time of consent (Blood pressure and heart rate control medications)
Exclusion Criteria
* Documented Pre-op Myocardium Injury
* Refused or unable to give informed consent
* Laparoscopic fundoplication
* Laparoscopic cholecystectomy surgery
* Appendectomy surgery
* Hernia repair surgery
Sample Size:
This is a prospective study to determine the incidence of myocardial injury in gastrointestinal surgical patients. There are no existing data upon which to base a sample size calculation. We estimate that data from 100 patients should provide a sufficient sample size to generate a reasonably robust incidence estimate. However, if the included centers recruit more patients they will be included in our analysis
Statistical Analysis:
Statsdirect will be used for analysis of the study results Budget No additional budget for the study will be needed as tests required routinely requested within the study clinical setting. The analysis and management of the study will be performed by clinical research fellow funded by National University of Ireland Galway
Conflict of interest:
Study team declare no conflict of interest
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gastrointestinal surgery
Major resectional gastrointestinal surgery (define as resection of part of gastrointestinal tract during esophageal, Gastric or colorectal surgeries)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Refused or unable to give informed consent
* Laparoscopic fundoplication
* Laparoscopic cholecystectomy surgery
* Appendectomy surgery
* Hernia repair surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Midland Regional Hospital, Tullamore
OTHER
Mayo University Hospital
UNKNOWN
Letterkenny University Hospital
UNKNOWN
University College Hospital Galway
OTHER
National University of Ireland, Galway, Ireland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
KHALID AHMED
Mr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Collage Hospital Galway
Galway, Co Galway, Ireland
Letterkenny University Hospital
Letterkenny, Donegal, Ireland
Mayo University Hospital
Castlebar, Mayo, Ireland
Midland Regional Hospital, Tullamore
Tullamore, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C.A 1518
Identifier Type: -
Identifier Source: org_study_id